The emerging therapy of this peptide represents a major breakthrough in the management of type 2 diabetes. Different to existing drugs, tirzepatide impacts dual pathways – GLP-1 and the GIP hormone – leading to https://tirzepatide-peptide086030.dgbloggers.com/42506274/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment